World’s first CRISPR-based therapy to be offered on the NHS in England

Groundbreaking therapy, known as exagamglogene autotemcel (brand name Casgevy®), has been approved for use on the NHS in England, offering patients the prospect of a cure for severe sickle cell disease.

20 years and 1000 cases

We bring a rich history working with pioneers of their time on mission-critical, life-changing and industry-advancing innovations. For Panduit, a world-leading network infrastructure developer, we’re more than an extension of their in-house team. We’re family.

See why clients choose us

Client quote:

'I have often said that no one will out think, out prepare or out perform you. I am glad you are on our side!'

Our services have helped our clients’ innovations make a real difference; from the steel of the Golden Gate Bridge to cutting-edge cancer fighting pharmaceuticals.

Accolades

News & Updates

LNPs: Small lipids, big potential in nucleic acid delivery

Lipid nanoparticles (LNPs) have emerged as a leading pharmaceutical formulation technology, particularly for nucleic acid delivery.

Kilburn & Strode announce this year’s Partner and Counsel promotions

These promotions continue our commitment to advancing our people, investing in everyone's development, whilst looking to our future.

Prior use ''pitfalls'' – three key tips for success in EPO oppositions

This practical update takes a look at how best to use public prior use in an EPO opposition and the potential pitfalls to avoid.

Upcoming events

30 April 2025 - RNA technologies: pitfalls and patent drafting tips in Europe

In the wake of vaccine development during the COVID-19 pandemic, the value of RNA technologies is at an all-time high.

Celebrating diversity: IP Inclusive

Fiercely committed to diversity, equity and inclusion, we were one of the first signatories of the IP Inclusive Charter, making a public commitment to supporting and promoting DEI in the IP professions. Additionally, we were founding members of IP Out, our LGBT+ chapter, and we regularly host events for Senior Women in IP and on neurodiversity, sustainability, and more.

Technology for Good

We care about the wider innovation and technology community, which is why we donate 1% of all annual profits to the Kilburn & Strode Innovation for All Foundation – thereby giving everyone the chance to both innovate and prosper. Our company’s existence is not isolated. It’s part of a wider system of people, values, other organisations and nature.

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us